Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior

Journal of Neurochemistry

Volumn 120, Issue 5, 2012, Pages 779-794

  Horner, Kristen A ^a   Hebbard, John C ^a   Logan, Anna S ^a   Vanchipurakel, Golda A ^a   Gilbert, Yamiece E ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

behavior; caudate putamen; immediate early gene; opioid; psychostimulant

Indexed keywords

DYNORPHIN; MESSENGER RNA; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; GENE EXPRESSION; IMMEDIATE EARLY GENE; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PRODYNORPHIN GENE; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; SPRAGUE DAWLEY RAT; STEREOTYPY; ZIF 268 GENE;

ANALGESICS, OPIOID; ANIMALS; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EARLY GROWTH RESPONSE PROTEIN 1; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RNA, MESSENGER; STEREOTYPED BEHAVIOR; TIME FACTORS;

RATTUS;

EID: 84857191691     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07620.x     Document Type: Article

References (75)

1. Adams A. C., Layer R. T., McCabe R. T., and, Keefe K. A,. (2000) Effects of conantokins on L-3, 4-dihydroxyphenylalanine-induced behavior and immediate early gene expression. Eur. J. Pharmacol. 404, 303-313.
2. Adams D. H., Hanson G. R., and, Keefe K. A., (2001) Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102, 843-851.
3. Adams D. H., Hanson G. R., and, Keefe K. A., (2003) Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix. J. Neurochem. 84, 87-93.
4. Aliane V., Perez S., Nieoullon A., Deniau J. M., and, Kemel M. L., (2009) Cocaine-induced stereotypy is linked to an imbalance between the medial prefrontal and sensorimotor circuits of the basal ganglia. Eur. J. Neurosci. 30, 1269-1279.
5. Bolam J. P., Izzo P. N., and, Graybiel A. M., (1988) Cellular substrate of the histochemically defined striosome and matrix system of the caudate nucleus: a combined golgi and immunohistochemical study. Neuroscience 24, 853-875.
6. Canales J. J,. (2005) Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol. Learn. Mem. 83, 93-103.
7. Canales J. J., and, Graybiel A. M., (2000) A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 3, 377-383.
8. Capper-Loup C., Canales J. J., Kadaba N., and, Graybiel A. M., (2002) Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22, 6218-6227.
9. Christy B. A., Lau L. F., and, Nathans D., (1988) A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. USA 85, 7857-7861.
10. Civelli O., Douglass J., Goldstein A., and, Herbert E., (1985) Sequence and expression of the rat dynorphin gene. Proc. Natl Acad. Sci. USA 82, 4291-4295.
11. Cole R. L., Konradi C., Douglass J., and, Hyman S. E., (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823.
12. Curran T., Gordon M. B., Rubinko K. L., and, Sambucetti L. C., (1987) Isolation and characterization of the c-fos (rat) cDNA and analysis of posttranslational modification in vitro. Oncogene 2, 79-84.
13. Frankel P. S., Hoonakker A. J., Danaceau J. P., and, Hanson G. R., (2007) Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine. Pharmacol. Biochem. Behav. 86, 511-515.
14. Gerfen C. R., (1984) The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311, 461-464.
15. Gerfen C. R., (1989) The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 246, 385-388.
16. Gerfen C. R., (1992a) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15, 133-139.
17. Gerfen C. R., (1992b) The neostriatal mosaic: multiple levels of compartmental organization. J. Neural Transm. Suppl. 36, 43-59.
18. Gerfen C. R., and, Wilson C. J., (1996) Integrated Systems of the CNS. Elsevier Sciences, Amsterdam.
19. Ginty D. D., (1997) Calcium regulation of gene expression: isn't that spatial? Neuron 18, 183-186.
20. Glickstein S. B., and, Schmauss C., (2004) Focused motor stereotypies do not require enhanced activation of neurons in striosomes. J. Comp. Neurol. 469, 227-238.
21. Gonzalez-Nicolini M. V., Berglind W., Cole K. S., Keogh C. L., and, McGinty J. F., (2003) Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 121, 387-398.
22. Graybiel A. M., (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
23. Graybiel A. M., and, Canales J. J., (2000) The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Adv. Neurol. 85, 123-131.
24. Graybiel A. M., Canales J. J., and, Capper-Loup C., (2000) Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 23, S71-S77.
25. Hanson G. R., Merchant K. M., Letter A. A., Bush L., and, Gibb J. W., (1987) Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur. J. Pharmacol. 144, 245-246.
26. Hardingham G. E., Chawla S., Johnson C. M., and, Bading H., (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265.
27. Harlan R. E., and, Garcia M. M., (1998) Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16, 221-267.
28. Heidbreder C. A., Goldberg S. R., and, Shippenberg T. S., (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616, 335-338.
29. Herkenham M., and, Pert C. B., (1981) Mosaic distibution of opiate receptors, parafascilular projections and acetylcholinesterase in rat striatum. Nature 291, 415-418.
30. Horner K. A., and, Keefe K. A., (2006) Regulation of psychostimulant- induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade. Eur. J. Pharmacol. 532, 61-73.
31. Horner K. A., Adams D. H., Hanson G. R., and, Keefe K. A., (2005) Blockade of stimulant-induced preprodynoprhin mRNA expression in the rat striatal matrix by serotonin depletion. Neuroscience 131, 67-77.
32. Horner K. A., Noble E. S., and, Lauterbach E. C., (2009) Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine. Synapse 63, 257-268.
33. Horner K. A., Noble E. S., and, Gilbert Y. E., (2010) Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation. Pharmacol. Biochem. Behav. 95, 410-421.
34. Ito R., Dalley J. W., Robbins T. W., and, Everitt B. J., (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci., Off. J. Soc. Neurosci. 22, 6247-6253.
35. Kawaguchi Y., (1992) Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J. Neurophysiol. 67, 1669-1682.
36. Kawashima T., Okuno H., Nonaka M., Adachi-Morishima A., Kyo N., Okamura M., Takemoto-Kimura S., Worley P. F., and, Bito H., (2009) Synaptic activity-responsive element in the Arc/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons. Proc. Natl. Acad. Sci. USA 106, 316-321.
37. Keefe K. A., and, Gerfen C. R., (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66, 903-913.
38. Lan K. C., Chang A. C., Liu S. H., Ho I. K., and, Lin-Shiau S. Y., (2009) Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice. J. Neurochem. 109, 382-392.
39. Lyford G. L., Yamagata K., Kaufmann W. E., Barnes C. A., Sanders L. K., Copeland N. G., Gilbert D. J., Jenkins N. A., Lanahan A. A., and, Worley P. F., (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433-445.
40. Macey T. A., Lowe J. D., and, Chavkin C., (2006) Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J. Biol. Chem. 281, 34515-34524.
41. Margolis E. B., Hjelmstad G. O., Bonci A., and, Fields H. L., (2003) Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J. Neurosci. 23, 9981-9986.
42. Meshul C. K., and, McGinty J. F., (2000) Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96, 91-99.
43. Milbrandt J., (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238, 797-799.
44. Moratalla R., Robertson H. A., and, Graybiel A. M., (1992) Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12, 2609-2622.
45. Moratalla R., Vallejo M., Elibol B., and, Graybiel A. M., (1996) D1-class dopamine receptors influence cocaine-induced persistent expression of Fos-related proteins in striatum. Neuroreport 8, 1-5.
46. Parthasarathy H. B., and, Graybiel A. M., (1997) Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci., Off. J. Soc. Neurosci. 17, 2477-2491.
47. Paxinos G., and, Watson C., (2005) The Rat Brain in Stereotaxic Coordinates. Elsevier Academic Press, San Diego, CA.
48. Pereira F. C., Lourenco E., Milhazes N., Morgadinho T., Ribeiro C. F., Ali S. F., and, Macedo T. R., (2006) Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats. Ann. N Y Acad. Sci. 1074, 160-173.
49. Pert C. B., Kuhar M., and, Snyder S. H., (1976) Opiate receptor: autoradiographic localization in the rat brain. Proc. Natl Acad. Sci. USA 73, 3729-3733.
50. Ragsdale C. W., Jr., and, Graybiel A. M., (1988) Fibers from the basolateral amygdala selectively innervate the striosomes in the caudate nucleus of the cat. J. Comp. Neurol. 269, 506-522.
51. Saka E., Iadarola M., Fitzgerald D. J., and, Graybiel A. M., (2002) Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc. Natl. Acad. Sci. USA 99, 9004-9009.
52. Sassone-Corsi P., Visvader J., Ferland L., Mellon P. L., and, Verma I. M., (1988) Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 2, 1529-1538.
53. Sgambato V., Abo V., Rogard M., Besson M. J., and, Deniau J. M., (1997) Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81, 93-112.
54. Sgambato V., Pages C., Rogard M., Besson M. J., and, Caboche J., (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814-8825.
55. Smith A. D., and, Bolam J. P., (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13, 259-265.
56. Steiner H., and, Gerfen C. R., (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123, 60-76.
57. Steward O., and, Worley P. F., (2001) Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron 30, 227-240.
58. Steward O., Wallace C. S., Lyford G. L., and, Worley P. F., (1998) Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 21, 741-751.
59. Tan A., Moratalla R., Lyford G., Worley P. F., and, Graybiel A. M., (2000) The activity-regulated cytoskeletal-associated protein Arc is expressed in different striosome-matrix patterns following exposure to amphetamine and cocaine. J. Neurochem. 74, 2074-2078.
60. Tempel A., and, Zukin R. S., (1987) Neuroanatomical patterns of the mu, delta and kappa opioid receptors of the rat brain as determined by quantitative in vitro autoradiography. Proc. Natl Acad. Sci. USA 43, 4308-4312.
61. Tepper J. M., and, Bolam J. P., (2004) Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 14, 685-692.
62. Toyoshi T., Ukai M., and, Kameyama T., (1996) Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse. Biol. Pharm. Bull. 19, 369-374.
63. Ujike H., Onoue T., Akiyama K., Hamamura T., and, Otsuki S., (1989) Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98, 89-92.
64. Walker J. M., Thompson L. A., Frascella J., and, Friederich M. W., (1987) Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur. J. Pharmacol. 134, 53-59.
65. Walker R. H., Arbuthnott G. W., Baughman R. W., and, Graybiel A. M., (1993) Dendritic domains of medium spiny neurons in the primate striatum: relationship to striosomal borders. J. Comp. Neurol. 337, 614-628.
66. Wang J. Q., and, McGinty J. F., (1995) Dose-dependent alterations in zif/268 and preprodynorphin mRNA exprsesion induced by amphetamine and methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273, 909-917.
67. Wang H., and, Pickel V. M., (1998) Dendritic spines containing mu-opioid receptors in rat striatal patches receive asymmetric synapses from prefrontal corticostriatal afferents. J. Comp. Neurol. 396, 223-237.
68. Wang J. Q., Smith A. J., and, McGinty J. F., (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in the rat forebrain. Neuroscience 68, 83-95.
69. Wang H., Moriwaki A., Wang J. B., Uhl G. R., and, Pickel V. M,. (1996) Ultrastructural immunocytochemical localization of mu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp. Neurol. 375, 659-674.
70. Wang H., Moriwaki A., Wang J. B., Uhl G. R., and, Pickel V. M., (1997) Ultrastructural immunocytochemical localization of mu-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus. Neuroscience 81, 757-771.
71. Wang D., Tolbert L. M., Carlson K. W., and, Sadee W., (2000) Nuclear Ca2+/calmodulin translocation activated by mu-opioid (OP3) receptor. J. Neurochem. 74, 1418-1425.
72. Woo S. K., Hitzemann R. J., and, Loh H. H., (1985) Specific opioid-amphetamine interactions in the caudate putamen. Psychopharmacology (Berl) 85, 371-376.
73. Yamagata K., Suzuki K., Sugiura H., Kawashima N., and, Okuyama S., (2000) Activation of an effector immediate-early gene arc by methamphetamine. Ann. N Y Acad. Sci. 914, 22-32.
74. Yin H. H., and, Knowlton B. J,. (2006) The role of the basal ganglia in habit formation. Nature Rev Neurosci. 7, 464-476.
75. You Z. B., Herrera-Marschitz M., and, Terenius L., (1999) Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J. Pharmacol. Exp. Ther. 290, 1307-1315.